ROCKVILLE, MD and SHENZHEN, CHINA, October 25, 2022 — HighTide Therapeutics, Inc. (“HighTide”), a clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases

ROCKVILLE, MD and SHENZHEN, CHINA , October 20, 2022 — HighTide Therapeutics, Inc. (“HighTide”), a clinical-stage biopharmaceutical company developing multifunctional therapies for metabolic and digestive diseases,

ROCKVILLE, MD and SHENZHEN, CHINA, October 14, 2022 HighTide Therapeutics Inc., a clinical-stage biopharmaceutical company developing multifunctional therapies for metabolic and digestive diseases,